Skip to content

Block Duration After Spinal Block and iv Dexamethasone.

Block Duration After Spinal Block and iv Dexamethasone: a Randomized Controlled Double-blinded Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03527576
Enrollment
50
Registered
2018-05-17
Start date
2018-05-01
Completion date
2022-04-01
Last updated
2022-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Limb Injury, Postoperative Pain

Brief summary

It has been largely demonstrated that iv dexamethasone prolongs the duration of analgesia after peripheral nerve block. However, data are missing regarding the duration of analgesia after spinal block. The objective of this randomized controlled double-blinded trial is to assess whether intravenous dexamethasone administered after a spinal block, before the surgery would prolong sensory block characteristics without impacting the motor block duration.

Interventions

DRUGDexamethasone

Intravenous injection of 0.15 mg/kg of dexamethasone before the surgery.

DRUGNaCl 0.0308 MEQ/ML Injectable Solution

Intravenous injection of NaCl 0.9% before the surgery.

Sponsors

Eric Albrecht
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient with ASA I-III status ; * Patient scheduled for an osteosynthesis surgy of the lower limb

Exclusion criteria

* Polytrauma patient * Pregnancy * Contraindication to spinal anesthesia * Contraindication to dexamethasone administration * Patient with chronic pain

Design outcomes

Primary

MeasureTime frameDescription
Duration of sensory block (minutes)Postoperative day 0Time interval between injection of the local anaesthetic and the regression of 2 dermatoma, compared to the highest dermatoma reached

Secondary

MeasureTime frameDescription
Pain score if persistent pain3 and 6 postoperative monthsNumeric rating scale (0-10)
Highest dermatoma reached (level)Postoperative day 0
Onset time between injection and highest dermatoma (minutes)Postoperative day 0
Total duration of the sensory block (minutes)Postoperative day 0
Total duration of the motor block (minutes)Postoperative day 0
Time to the first analgesic request (minutes)Postoperative day 0
Persistent pain3 and 6 postoperative monthsYES/NO
Pain scorePostoperative days 0, 1 and 2Numeric rating scale (0-10)
Rate of postoperative nausea and vomitingPostoperative day 0, 1 and 2YES/NO
Rate of pruritusPostoperative day 0, 1 and 2YES/NO
Rate of urinary retentionPostoperative day 1 and 2YES/NO
Satisfaction levelPostoperative day 2Numeric rating scale (0-10)
Length of stayup to 14 daysDays
Cumulative consumption of morphine (mg)Postoperative days 0, 1 and 2

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026